LALANI, A.-K. A. .; CHI, K. N. .; HENG, D. Y. .; KOLLMANNSBERGER, C. K. .; SRIDHAR, S. S. .; BLAIS, N. .; CANIL, C. .; CZAYKOWSKI, P. .; HOTTE, S. J. .; IQBAL, N. .; SOULIÈRES, D. .; BOSSÉ, D. .; ALIMOHAMED, N. S. .; BASAPPA, N. S. .; MUKHERJEE, S. D. .; WINQUIST, E. .; WOOD, L. A. .; NORTH, S. A. . Prioritizing systemic therapies for genitourinary malignancies: Canadian recommendations during the COVID-19 pandemic. Canadian Urological Association Journal, [S. l.], v. 14, n. 5, 2020. DOI: 10.5489/cuaj.6595. Disponível em: https://cuaj.ca/index.php/journal/article/view/6595. Acesso em: 28 mar. 2024.